Cargando…
Monoamine depletion by reuptake inhibitors
BACKGROUND: Disagreement exists regarding the etiology of cessation of the observed clinical results with administration of reuptake inhibitors. Traditionally, when drug effects wane, it is known as tachyphylaxis. With reuptake inhibitors, the placebo effect is significantly greater than the drug ef...
Autores principales: | Hinz, Marty, Stein, Alvin, Uncini, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237392/ https://www.ncbi.nlm.nih.gov/pubmed/22171164 http://dx.doi.org/10.2147/DHPS.S24798 |
Ejemplares similares
-
The discrediting of the monoamine hypothesis
por: Hinz, Marty, et al.
Publicado: (2012) -
Relative nutritional deficiencies associated with centrally acting monoamines
por: Hinz, Marty, et al.
Publicado: (2012) -
The dual-gate lumen model of renal monoamine transport
por: Hinz, Marty, et al.
Publicado: (2010) -
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
por: Hinz, Marty, et al.
Publicado: (2011) -
Monoamine Depletion by Reuptake Inhibitors [Retraction]
Publicado: (2020)